Solasia Pharma KK(JP:4597)
Â¥24.00+1.00 (+4.35%)
JP:4597
Solasia Pharma KK financials statements
Â¥24.00
At close:+1.00 (+4.35%)
Want to see JP:4597 full AI Analyst Report?
Solasia Pharma KK (4597) Ratios
1 Followers
Solasia Pharma KK Ratios
JP:4597's free cash flow for Q2 2026 was ¥-262.00M. For the 2026 fiscal year, JP:4597's free cash flow was increased by ¥0.00 and operating cash flow was ¥-262.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 6.06 | 6.56 | 3.33 | 3.53 | 1.83 |
| Quick Ratio | 5.70 | 5.90 | 2.91 | 3.49 | 1.83 |
| Cash Ratio | 4.45 | 4.59 | 2.48 | 1.97 | 1.46 |
| Solvency Ratio | -2.14 | -8.60 | -1.73 | -4.27 | -3.56 |
| Operating Cash Flow Ratio | -2.71 | -5.35 | -1.23 | -5.10 | -5.06 |
| Short-Term Operating Cash Flow Coverage | -27.32 | 0.00 | -10.88 | -56.05 | -52.62 |
| Net Current Asset Value | ¥ 1.50B | ¥ 1.06B | ¥ 622.00M | ¥ 963.00M | ¥ 337.00M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.02 | 0.03 | 0.01 | 0.03 |
| Debt-to-Equity Ratio | 0.09 | 0.02 | 0.03 | 0.01 | 0.03 |
| Debt-to-Capital Ratio | 0.08 | 0.02 | 0.03 | 0.01 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.22 | 1.18 | 1.19 | 1.18 | 1.22 |
| Debt Service Coverage Ratio | -18.27 | -155.40 | -18.58 | -36.29 | -27.99 |
| Interest Coverage Ratio | -61.36 | -198.20 | 0.00 | -137.28 | -105.17 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.73 | 0.15 | 0.36 | 0.36 | 0.82 |
| Net Debt to EBITDA | 1.49 | 1.08 | 1.05 | 0.39 | 0.33 |
| Profitability Margins | |||||
| Gross Profit Margin | 39.86% | -3.16% | 54.62% | 60.62% | 66.91% |
| EBIT Margin | -200.23% | -313.61% | -183.95% | -226.56% | -432.74% |
| EBITDA Margin | -191.61% | -251.90% | -102.92% | -177.66% | -344.19% |
| Operating Profit Margin | -200.23% | -313.61% | -184.60% | -226.28% | -432.74% |
| Pretax Profit Margin | -204.20% | -620.57% | -183.95% | -228.21% | -436.85% |
| Net Profit Margin | -204.20% | -614.24% | -180.23% | -233.33% | -443.11% |
| Continuous Operations Profit Margin | -204.20% | -614.56% | -180.39% | -233.33% | -443.11% |
| Net Income Per EBT | 100.00% | 98.98% | 97.97% | 102.25% | 101.43% |
| EBT Per EBIT | 101.98% | 197.88% | 99.65% | 100.85% | 100.95% |
| Return on Assets (ROA) | -40.84% | -142.51% | -49.89% | -81.30% | -78.78% |
| Return on Equity (ROE) | -50.00% | -167.91% | -59.31% | -95.72% | -95.75% |
| Return on Capital Employed (ROCE) | -46.86% | -84.77% | -58.83% | -90.61% | -91.11% |
| Return on Invested Capital (ROIC) | -46.08% | -82.19% | -55.79% | -88.25% | -88.03% |
| Return on Tangible Assets | -40.84% | -142.51% | -100.00% | -162.92% | -232.58% |
| Earnings Yield | -12.72% | -27.13% | -14.70% | -34.21% | -17.79% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.15 | 1.36 | 9.21 | 1.91 | 4.44 |
| Payables Turnover | 1.13 | 2.69 | 1.31 | 1.30 | 0.48 |
| Inventory Turnover | 2.30 | 2.55 | 2.30 | 30.71 | 0.00 |
| Fixed Asset Turnover | 3.80 | 6.58 | 7.62 | 17.33 | 4.66 |
| Asset Turnover | 0.20 | 0.23 | 0.28 | 0.35 | 0.18 |
| Working Capital Turnover Ratio | 0.32 | 0.36 | 0.72 | 1.52 | 0.70 |
| Cash Conversion Cycle | 152.68 | 275.81 | -78.99 | -78.74 | -679.30 |
| Days of Sales Outstanding | 318.21 | 267.97 | 39.64 | 191.19 | 82.27 |
| Days of Inventory Outstanding | 158.45 | 143.31 | 159.04 | 11.88 | 0.00 |
| Days of Payables Outstanding | 323.97 | 135.48 | 277.66 | 281.81 | 761.57 |
| Operating Cycle | 476.65 | 411.29 | 198.67 | 203.07 | 82.27 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -3.57 | -5.20 | -2.14 | -13.65 | -19.00 |
| Free Cash Flow Per Share | -3.57 | -5.20 | -2.14 | -16.30 | -20.25 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -1033.00 | 0.00 | -5.15 | -15.17 |
| Capital Expenditure Coverage Ratio | 0.00 | -1033.00 | 0.00 | -5.15 | -15.17 |
| Operating Cash Flow Coverage Ratio | -5.33 | -41.32 | -5.98 | -56.05 | -29.44 |
| Operating Cash Flow to Sales Ratio | -1.97 | -3.27 | -0.58 | -1.90 | -4.42 |
| Free Cash Flow Yield | -12.30% | -14.45% | -4.74% | -33.26% | -18.93% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -7.86 | -3.68 | -6.80 | -2.92 | -5.62 |
| Price-to-Sales (P/S) Ratio | 16.06 | 22.64 | 12.26 | 6.82 | 24.91 |
| Price-to-Book (P/B) Ratio | 3.93 | 6.19 | 4.04 | 2.80 | 5.38 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -8.13 | -6.92 | -21.08 | -3.01 | -5.28 |
| Price-to-Operating Cash Flow Ratio | -8.13 | -6.92 | -21.08 | -3.59 | -5.63 |
| Price-to-Earnings Growth (PEG) Ratio | 0.13 | -0.08 | 0.11 | 0.25 | 0.12 |
| Enterprise Value Multiple | -6.89 | -7.90 | -10.86 | -3.44 | -6.91 |
| Enterprise Value | 5.66B | 6.29B | 6.90B | 6.68B | 13.30B |
| EV to EBITDA | -6.89 | -7.90 | -10.86 | -3.44 | -6.91 |
| EV to Sales | 13.19 | 19.91 | 11.18 | 6.12 | 23.79 |
| EV to Free Cash Flow | -6.68 | -6.09 | -19.21 | -2.70 | -5.04 |
| EV to Operating Cash Flow | -6.68 | -6.09 | -19.21 | -3.22 | -5.38 |
| Tangible Book Value Per Share | 7.38 | 5.83 | 4.51 | 7.18 | 3.90 |
| Shareholders’ Equity Per Share | 7.38 | 5.82 | 11.15 | 17.51 | 19.88 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.01 | 0.02 | -0.02 | -0.01 |
| Revenue Per Share | 1.81 | 1.59 | 3.67 | 7.18 | 4.30 |
| Net Income Per Share | -3.69 | -9.77 | -6.61 | -16.76 | -19.03 |
| Tax Burden | 1.00 | 0.99 | 0.98 | 1.02 | 1.01 |
| Interest Burden | 1.02 | 1.98 | 1.00 | 1.01 | 1.01 |
| Research & Development to Revenue | 1.00 | 1.31 | 0.65 | 0.81 | 1.51 |
| SG&A to Revenue | 1.48 | 1.79 | 1.74 | 2.06 | 3.48 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.97 | 0.53 | 0.32 | 0.83 | 1.01 |
Currency in JPY
